Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Naxpar Pharma is a leading Indian pharmaceutical manufacturing company and a key subsidiary of the publicly traded Parnax Lab Limited. Founded in 1985, the company specializes in the contract development and manufacturing (CDMO) of finished formulations, including oral liquids, tablets, capsules, ointments, and creams, as well as cosmetics, herbal/Ayurvedic formulations, and nutraceuticals. Naxpar Pharma operates state-of-the-art, WHO-GMP compliant manufacturing facilities in Silvassa and Baddi, serving major multinational corporations and exporting products to emerging markets across Asia, Africa, the Middle East, and Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Naxpar Pharma.